XML 77 R64.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings per share - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Apr. 01, 2023
Apr. 02, 2022
Numerator:    
Net loss from continuing operations $ (100,018) $ (14,405)
Loss attributable to noncontrolling interest - continuing operations 20,360 3,529
Net loss attributable to Bioventus Inc. Class A common stockholders — continuing operations (79,658) (10,876)
Net (loss) income from discontinued operations, net of tax (74,429) (401)
Loss attributable to noncontrolling interest - discontinued operations 14,937 0
Net loss attributable to Bioventus Inc. Class A common stockholders — discontinued operations $ (59,492) $ (401)
Denominator:    
Weighted-average shares of Class A common stock outstanding - basic (in shares) 62,124,752 60,484,969
Weighted-average shares of Class A common stock outstanding - diluted (in shares) 62,124,752 60,484,969
Net loss per share of Class A common stock from continuing operations, diluted (in dollars per share) $ (1.28) $ (0.18)
Net loss per share of Class A common stock from continuing operations, basic (in dollars per share) (1.28) (0.18)
Net loss per share of Class A common stock from discontinuing operations, diluted (in dollars per share) (0.96) (0.01)
Net loss per share of Class A common stock from discontinuing operations, basic (in dollars per share) (0.96) (0.01)
Net loss per share of class A common stock, basic (in dollars per share) (2.24) (0.19)
Net loss per share of class A common stock, diluted (in dollars per share) $ (2.24) $ (0.19)